Skip to content

The effect of critical ultrasonography guided precise fluid management (CUGP) in patients with sepsis or septic shock: a multi-center randomized controlled trial

The effect of critical ultrasonography guided precise fluid management (CUGP) in patients with sepsis or septic shock: a multi-center randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047792
Enrollment
Unknown
Registered
2021-06-26
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Experimental group:Critical ultrasonography guided precise fluid management.
Control group:Routine hemodynamic monitoring guided fluid management.

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=18 years; 2.The estimated length of ICU stay >=24 hours; 3.Patients who were diagnosed according to the sepsis diagnostic criteria (Sepsis-3) were included in this study: (1) Suspected or confirmed infections based on clinical evidence and/or positive in etiology; (2) The SOFA score (sepsis related organ failure assessment score) was >=2 .

Exclusion criteria

Exclusion criteria: 1.Pregnant; 2.Acute cerebrovascular accident; 3.Acute coronary syndrome; 4.Acute pulmonary edema; 5.Status asthmatics; 6.Malignant arrhythmia; 7.Active gastrointestinal bleeding; 8.Epileptic seizure; 9.Drug poisoning; 10.Severe burns; 11.Contraindications of blood transfusion; 12.Intraperitoneal hypertension (IAP >= 12mmHg and increased continuously); 13.Acute pulmonary embolism; 14.Contraindications of leg raising; 15.The patient or his agent ad litem refuses active treatment; 16.The patient or his agent ad litem refused to participate in this study; 17.The patient are participating in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
all-cause 60-day mortality;

Secondary

MeasureTime frame
Failure rate of critical ultrasound monitoring in intervention group;failure rate of conventional monitoring in the control group;total infusion quantity during Intensive Care Unit stay;dosage and duration of vasopressors during Intensive Care Unit stay;Incidence of complications;

Countries

China

Contacts

Public ContactLi Shusheng

Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

lishusheng@hust.edu.cn+86 13971086498

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026